Patents by Inventor Triantafyllos Stylianopoulos

Triantafyllos Stylianopoulos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANCER TREATMENT USING BOSENTAN IN COMBINATION WITH A CHECKPOINT INHIBITOR
    Publication number: 20240024317
    Abstract: The present invention is directed to a combination treatment using bosentan and a checkpoint inhibitor that is effective in treating cancer or inhibiting the proliferation of tumor cells in a subject and/or that can initiate, enhance or prolong the immune response to tumor cells.
    Type: Application
    Filed: December 9, 2021
    Publication date: January 25, 2024
    Inventors: John D. MARTIN, Triantafyllos STYLIANOPOULOS, Fotios MPEKRIS, Myrofora PANAGI, Chysovalantis VOUTOURI, Andreas STYLIANOU
  • Multistage Nanoparticles
    Publication number: 20160038609
    Abstract: Multistage nanostructures, e.g., for delivery of agents such as imaging agents and therapeutic agents to tumor vasculature.
    Type: Application
    Filed: March 9, 2015
    Publication date: February 11, 2016
    Inventors: Cliff Wong, Moungi G. Bawendi, Triantafyllos Stylianopoulos, Rakesh K. Jain, Dai Fukumura
  • Multistage Nanoparticles
    Publication number: 20130224282
    Abstract: Multistage nanostructures, e.g., for delivery of agents such as imaging agents and therapeutic agents to tumor vasculature.
    Type: Application
    Filed: September 21, 2011
    Publication date: August 29, 2013
    Applicants: MASSACHUSETTS INSTITUTE OF TECHNOLOGY, The General Hospital Corporation
    Inventors: Cliff Wong, Moungi G. Bawendi, Triantafyllos Stylianopoulos, Rakesh K. Jain, Dai Fukumura